Literature DB >> 27065658

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

Naveen Padmanabhan1, Muhamed Faizal Ayub1, Khadher Hussain1, Ann Kurien2, Selvi Radhakrishna3.   

Abstract

Current guidelines recommend completion axillary lymphnode dissection (ALND) when sentinel lymphnode (SLN) contains metastatic tumor deposit. In consequent ALND sentinel node is the only node involved by tumor in 40-70 % of cases. Recent studies demonstrate the oncologic safety of omitting completion ALND in low risk patients. Several nomograms (MSKCC, Stanford, MD Anderson score, Tenon score) had been developed in predicting the likelihood of additional nodes metastatic involvement. We evaluated accuracy of MSKCC nomogram and other clinicopathologic variables associated with additional lymph node metastasis in our patients. A total of 334 patients with primary breast cancer patients underwent SLN biopsy during the period Jan 2007 to June 2014. Clinicopathologic variables were prospectively collected. Completion ALND was done in 64 patients who had tumor deposit in SLN. The discriminatory accuracy of nomogram was analyzed using Area under Receiver operating characteristic curve (ROC). SLN was the only node involved with tumor in 69 % (44/64) of our patients. Additional lymph node metastasis was seen in 31 % (20/64). On univariate analysis, extracapsular infiltration in sentinel node and multiple sentinel nodes positivity were significantly associated (p < 0.05) with additional lymph node metastasis in the axilla. Area under ROC curve for nomogram was 0.58 suggesting poor performance of the nomogram in predicting NSLN involvement. Sentinel nodes are the only nodes to be involved by tumor in 70 % of the patients. Our findings indicate that multiple sentinel node positivity and extra-capsular invasion in sentinel node significantly predicted the likelihood of additional nodal metastasis. MSKCC nomogram did not reliably predict the involvement of additional nodal metastasis in our study population.

Entities:  

Keywords:  Breast cancer; MSKCC nomogram; Non-sentinel node metastasis; Sentinel node positive

Year:  2015        PMID: 27065658      PMCID: PMC4809847          DOI: 10.1007/s13193-015-0431-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  65 in total

1.  Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients.

Authors:  José Luis Fougo; Francisco Senhorães Senra; Cláudia Araújo; Teresa Dias; Mariana Afonso; Conceição Leal; Mário Dinis-Ribeiro
Journal:  Breast       Date:  2010-11-24       Impact factor: 4.380

2.  Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.

Authors:  I van den Hoven; G P Kuijt; A C Voogd; M W P M van Beek; R M H Roumen
Journal:  Br J Surg       Date:  2010-11       Impact factor: 6.939

Review 3.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

4.  Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion.

Authors:  N S Goldstein; A Mani; F Vicini; J Ingold
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

5.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

6.  Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.

Authors:  Laufey Tryggvadóttir; Mette Gislum; Freddie Bray; Asa Klint; Timo Hakulinen; Hans H Storm; Gerda Engholm
Journal:  Acta Oncol       Date:  2010-06       Impact factor: 4.089

7.  Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.

Authors:  R F D van la Parra; C M T P Francissen; P G M Peer; M F Ernst; W K de Roos; K J Van Zee; K Bosscha
Journal:  Eur J Cancer       Date:  2012-09-10       Impact factor: 9.162

8.  Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.

Authors:  Giovanni D'Eredità; Vito Leopoldo Troilo; Carmela Giardina; Anna Napoli; Giuseppe Rubini; Fernando Fischetti; Tommaso Berardi
Journal:  Clin Breast Cancer       Date:  2010-12-01       Impact factor: 3.225

9.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

10.  Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Authors:  Kathie-Ann Joseph; Mahmoud El-Tamer; Ian Komenaka; Andrea Troxel; Beth Ann Ditkoff; Freya Schnabel
Journal:  Arch Surg       Date:  2004-06
View more
  2 in total

1.  Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.

Authors:  Yang Yu; Zhijun Wang; Zhongyin Wei; Bofan Yu; Peng Shen; Yuan Yan; Wei You
Journal:  BMC Cancer       Date:  2021-04-26       Impact factor: 4.430

2.  Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node.

Authors:  Yidong Zhou; Xin Huang; Feng Mao; Yan Lin; Songjie Shen; Jinghong Guan; Xiaohui Zhang; Qiang Sun
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.